Connection

Danielle Porter to Antiretroviral Therapy, Highly Active

Back to Details
This is a "connection" page, showing publications Danielle Porter has written about Antiretroviral Therapy, Highly Active.
Danielle Porter
Connection Strength
0.437
Antiretroviral Therapy, Highly Active
  1. Viral blips were infrequent in treatment-naive adults treated with rilpivirine/emtricitabine/tenofovir DF or efavirenz/emtricitabine/tenofovir DF through 96 weeks. Antivir Ther. 2017; 22(6):495-502.
    View in: PubMed
    Score: 0.437
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.